This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sotgia, F. Articles by Lisanti, M. P. Search for Related Content PubMed PubMed Citation Articles by Sotgia, F. Articles by Lisanti, M. P. Related Collections Cellular Pathobiology Cellular Pathobiology: Cancer Genes and Genomics Cellular Pathobiology: Proliferation, Senescence, and Death

Caveolin-1, Mammary Stem Cells, and Estrogen-Dependent Breast Cancers

Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

Requests for reprints: Federica Sotgia and Michael P. Lisanti, Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, Philadelphia 19107, PA. Phone: 215-503-9295; Fax: 215-923-1098; E-mail: federica.sotgia{at}jefferson.edu and michael.lisanti{at}jefferson.edu.

Estrogen exposure is considered a significant risk factor for breast cancer development. Estrogen receptor (ER) is expressed at low levels in normal epithelia, and its expression is dramatically up-regulated as transformation progresses during mammary hyperplasia and adenocarcinoma development. The mechanism(s) driving ER up-regulation during mammary tumorigenesis remains unclear. Caveolin-1 (Cav-1) is the structural protein of plasmalemmal invaginations, termed caveolae, which functions as a tumor suppressor gene. Interestingly, Cav-1 dominant-negative mutations are exclusively found in ER-positive breast cancer samples. In support of these clinical findings, ER expression is increased in Cav-1 (–/–) null mammary epithelia, and estrogen stimulation further enhances the growth of Cav-1-deficient three-dimensional epithelial structures. These phenotypes correlate with augmented levels of cyclin D1. In addition, Cav-1 gene inactivation induces the accumulation of a cell population with the characteristics of adult mammary stem cells. Primary cultures of Cav-1 (–/–) mammary epithelial cells exhibit premalignant changes, such as abnormal lumen formation, epidermal growth factor–independent growth, defects in cell substrate attachment, and increased cell invasiveness. Thus, Cav-1 gene inactivation promotes premalignant alterations in mammary epithelia and induces increased ER expression levels and the up-regulation of cyclin D1. As tumor formation is a multihit process, Cav-1 mutations that occur during the early stages of mammary transformation may be a critical upstream/initiating event leading to increased ER levels. (Cancer Res 2006; 66(22): 10647-51)

This article has been cited by other articles:

				I. Mercier, M. C. Casimiro, J. Zhou, C. Wang, C. Plymire, K. G. Bryant, K. M. Daumer, F. Sotgia, G. Bonuccelli, A. K. Witkiewicz, et al. Genetic Ablation of Caveolin-1 Drives Estrogen-Hypersensitivity and the Development of DCIS-Like Mammary Lesions Am. J. Pathol., April 1, 2009; 174(4): 1172 - 1190. [Abstract] [Full Text] [PDF]

				R. Mamillapalli, J. VanHouten, W. Zawalich, and J. Wysolmerski Switching of G-protein Usage by the Calcium-sensing Receptor Reverses Its Effect on Parathyroid Hormone-related Protein Secretion in Normal Versus Malignant Breast Cells J. Biol. Chem., September 5, 2008; 283(36): 24435 - 24447. [Abstract] [Full Text] [PDF]

				P. G. Frank, S. Pavlides, M. W.-C. Cheung, K. Daumer, and M. P. Lisanti Role of caveolin-1 in the regulation of lipoprotein metabolism Am J Physiol Cell Physiol, July 1, 2008; 295(1): C242 - C248. [Abstract] [Full Text] [PDF]

				S.-H. Tan and M. T Nevalainen Signal transducer and activator of transcription 5A/B in prostate and breast cancers Endocr. Relat. Cancer, June 1, 2008; 15(2): 367 - 390. [Abstract] [Full Text] [PDF]

				L. Cantiani, M. C. Manara, C. Zucchini, P. De Sanctis, M. Zuntini, L. Valvassori, M. Serra, M. Olivero, M. F. Di Renzo, M. P. Colombo, et al. Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling Cancer Res., August 15, 2007; 67(16): 7675 - 7685. [Abstract] [Full Text] [PDF]